Lords Mark Industries Ltd

Lords Mark Industries Ltd

Lords Mark Industries Ltd has clarified that its equity shares are trading restricted due to IBC/IRP Stage-1, but this is a regulatory surveillance mechanism and not an indication of any adverse issue. The company has requested an exemption from BSE and is awaiting a response.

Lords Mark Industries Ltd

Lords Mark Industries Ltd has submitted an application to the National Stock Exchange of India Limited (NSE) for listing and trading approval of its existing equity shares, which are currently listed on BSE Limited. The proposed listing aims to provide an additional trading platform, enhance liquidity, and broaden the investor base.

Lords Mark Industries Ltd

Lords Mark Industries Ltd has issued a corrigendum to correct an inadvertent typographical error in its previous board meeting outcome announcement, stating that the issue price consideration was Rs. 10 per equity share instead of Rs. 195 per equity share (face value Rs. 10 and securities premium Rs. 185).

Lords Mark Industries Ltd

Lords Mark Industries Ltd has allotted 7,02,167 equity shares on a preferential basis to Mr. Satyaprakash Krishnarao, a non-resident Indian, pursuant to a court order and settlement agreement. The allotment is in compliance with SEBI and RBI regulations.

Lords Mark Industries Ltd

Lords Mark Industries Ltd has scheduled a Board Meeting on 13/08/2026 to consider and approve various items including standalone and consolidated unaudited financial results for the quarter ended 30th June, 2026.

Lords Mark Industries Ltd

Lords Mark Industries Ltd announced the resignation of its Company Secretary & Compliance Officer, Bhavini Rajkumar Chandnani, citing personal reasons. The notice period is one month, and the resignation will be effective from August 20, 2026. The Board will accept the resignation, file necessary disclosures, and settle all dues.

Lords Mark Industries Ltd

Lords Mark Industries Ltd announced that its Board of Directors approved a change in the company's registered office address within the local limits of Mumbai. The new office will be at B-101, Ridhi Sidhi Complex, M.G. Road, Borivali (East), Mumbai - 400066, effective June 23, 2026. This relocation from Nariman Point is cited for business exigencies and administrative convenience, remaining under the same Registrar of Companies jurisdiction.

Lords Mark Industries Ltd

Lords Mark Industries Ltd has commissioned a new 14,000 sq. ft. In Vitro Diagnostics (IVD) manufacturing facility in Vasai, Maharashtra, two months ahead of its August 2026 schedule. This expansion boosts the company's total operational manufacturing footprint to 34,000 sq. ft. and will produce 56 ELISA test kits and new rapid diagnostic test kits. The company also unveiled plans for a third facility by January 2029 dedicated to early cancer detection and a vision for establishing one of the world's largest AI-enabled medical device manufacturing facilities in India, emphasizing indigenous research and healthcare accessibility.